“互联网+”全生命周期药学服务对高血压、糖尿病、高脂血症患者治疗效果的研究  

Therapeutic Effect of"Internet+"Whole-Life-Cycle Pharmaceutical Care in Patients with Hypertension,Diabetes Mellitus and Hyperlipidemia

作　　者：谷永杰 郭倩倩[1] 郑兰 方圆 高君 王琛惠 杨林超 GU Yong-jie;GUO Qian-qian;ZHENG Lan;FANG Yuan;GAO Jun;WANG Chen-hui;YANG Lin-chao(Department of Pharmacy,the Fifth Clinical Medical College,Henan University of Chinese Medicine/People's Hospital of Zhengzhou,Zhengzhou 450000,China)

机构地区：[1]河南中医药大学第五临床医学院/郑州人民医院药学部,郑州450000

出　　处：《中国合理用药探索》2024年第6期82-86,共5页Chinese Journal of Rational Drug Use

基　　金：聚火优才全国药学服务科研项目(CMEAPC2023051);郑州市社会科学调研课题(ZSLX20220165);河南省医学科技计划(联合共建)项目(LHGJ20200682)。

摘　　要：目的:了解社区高血压、糖尿病、高脂血症患者的用药现状、达标情况及用药依从性,以期预防心血管事件的发生。方法:采用随机数字表法选取2022年1~6月在某院就诊的高血压、2型糖尿病、高脂血症患者100例作为对照组,社区义诊收集的高血压、2型糖尿病、高脂血症患者100例作为干预组。详细记录患者基本信息、用药情况及检验、检查结果,定期随访用药情况,血压、血糖、血脂等指标,及并发症、不良反应情况。根据干预组患者需求及梳理用药不适宜情况,指导患者用药,解答患者的咨询或疑虑,并给予就医指导。对照组只定期追踪血压、血糖、血脂等情况,解答患者的咨询及疑虑。结果:实施“互联网+”全生命周期药学服务后,两组患者血压、糖化血红蛋白、血脂水平均改善,且患者服药依从性提升。结论:关注社区高血压、糖尿病、高脂血症患者治疗过程中存在的问题并给予纠正与指导,能够提高患者的治疗率、控制率和用药依从性。Objective:To investigate the current medication situation,control rate and medication adherence of patients with hypertension,diabetes mellitus and hyperlipidemia in community,so as to prevent cardiovascular events.Methods:A total of 100 patients with hypertension,type 2 diabetes mellitus and hyperlipemia who visited a hospital from January to June 2022 were selected by the random number table method and included in the control group,and another 100 patients with hypertension,type 2 diabetes mellitus and hyperlipemia who visited community free clinics were included in the intervention group.The general information,medication and tests,examination results,regular follow-up medication,measures including blood pressure,blood glucose,blood lipids,etc.,complications,and adverse reactions were recorded in detail.Patients in the intervention group were instructed to use drugs and provided with advise to their consultation and response to their questions as well as medical guidance based on their needs and the collated contraindications.In the control group,only blood pressure,blood glucose and blood lipids were tracked regularly,and advice to patients'consultation and response to their questions were provided.Results:After the implementation of"Internet+"whole-life-cycle pharmaceutical care,the blood pressure,glycated hemoglobin and blood lipid levels of patients in both groups were improved,and the medication adherence was also promoted.Conclusion:Paying attention to the problems in the process of treating hypertension,diabetes mellitus and hyperlipemia in community and giving correction and guidance can promote the treatment rate,control rate and medication adherence among patients.

关 键 词：互联网+ 药学服务 高血压 糖尿病 高脂血症 依从性 

分 类 号：R969[医药卫生—药理学]